A breast cancer survivor gave a big gift to a Bay Area nonprofit that plans to change how cancer drugs reach patients.

Cyclophosphamide is a widely used alkylating agent that requires metabolic conversion to exert its antineoplastic effects. As a prodrug, it undergoes hepatic bioactivation predominantly via cytochrome ...

Cyclophosphamide is a generic injectable solution and capsule prescribed to treat conditions such as certain cancers and nephrotic syndrome. The cost of cyclophosphamide, with and without insurance, ...

Nexus Pharmaceuticals shared that on May 9, 2025, it won a patent litigation involving injectable cyclophosphamide, a drug that has been approved for certain kinds of cancer. Nexus had been pursuing a ...

Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, Brazil We retrospectively reviewed our institutional database to identify ...

Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...

Clinicopathological features and prognostic implications of HER2-low in early-stage male breast cancer: A retrospective analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.